These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 16807369)
1. Interaction of HIV Tat and matrix metalloproteinase in HIV neuropathogenesis: a new host defense mechanism. Rumbaugh J; Turchan-Cholewo J; Galey D; St Hillaire C; Anderson C; Conant K; Nath A FASEB J; 2006 Aug; 20(10):1736-8. PubMed ID: 16807369 [TBL] [Abstract][Full Text] [Related]
2. Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif. Mishra M; Vetrivel S; Siddappa NB; Ranga U; Seth P Ann Neurol; 2008 Mar; 63(3):366-76. PubMed ID: 18074388 [TBL] [Abstract][Full Text] [Related]
3. Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenyl. Turchan-Cholewo J; Liu Y; Gartner S; Reid R; Jie C; Peng X; Chen KC; Chauhan A; Haughey N; Cutler R; Mattson MP; Pardo C; Conant K; Sacktor N; McArthur JC; Hauser KF; Gairola C; Nath A Neurobiol Dis; 2006 Jul; 23(1):109-19. PubMed ID: 16697650 [TBL] [Abstract][Full Text] [Related]
4. An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity. Zauli G; La Placa M; Vignoli M; Re MC; Gibellini D; Furlini G; Milani D; Marchisio M; Mazzoni M; Capitani S J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):306-16. PubMed ID: 7552492 [TBL] [Abstract][Full Text] [Related]
5. Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Nath A; Haughey NJ; Jones M; Anderson C; Bell JE; Geiger JD Ann Neurol; 2000 Feb; 47(2):186-94. PubMed ID: 10665489 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of HIV-1 Tat-mediated transactivation by quinacrine and chloroquine. Jiang MC; Lin JK; Chen SS Biochem Biophys Res Commun; 1996 Sep; 226(1):1-7. PubMed ID: 8806583 [TBL] [Abstract][Full Text] [Related]
7. Effects of apolipoprotein E on the human immunodeficiency virus protein Tat in neuronal cultures and synaptosomes. Pocernich CB; Sultana R; Hone E; Turchan J; Martins RN; Calabrese V; Nath A; Butterfield DA J Neurosci Res; 2004 Aug; 77(4):532-9. PubMed ID: 15264223 [TBL] [Abstract][Full Text] [Related]
8. Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR. Harhaj E; Blaney J; Millhouse S; Sun SC Virology; 1996 Feb; 216(1):284-7. PubMed ID: 8615004 [TBL] [Abstract][Full Text] [Related]
9. Luman, a new partner of HIV-1 TMgp41, interferes with Tat-mediated transcription of the HIV-1 LTR. Blot G; Lopez-Vergès S; Treand C; Kubat NJ; Delcroix-Genête D; Emiliani S; Benarous R; Berlioz-Torrent C J Mol Biol; 2006 Dec; 364(5):1034-47. PubMed ID: 17054986 [TBL] [Abstract][Full Text] [Related]
10. A protein phosphatase from human T cells augments tat transactivation of the human immunodeficiency virus type 1 long-terminal repeat. Bharucha DC; Zhou M; Nekhai S; Brady JN; Shukla RR; Kumar A Virology; 2002 Apr; 296(1):6-16. PubMed ID: 12036313 [TBL] [Abstract][Full Text] [Related]
11. Thrombospondin-1/HIV-1 tat protein interaction: modulation of the biological activity of extracellular Tat. Rusnati M; Taraboletti G; Urbinati C; Tulipano G; Giuliani R; Molinari-Tosatti MP; Sennino B; Giacca M; Tyagi M; Albini A; Noonan D; Giavazzi R; Presta M FASEB J; 2000 Oct; 14(13):1917-30. PubMed ID: 11023976 [TBL] [Abstract][Full Text] [Related]
12. The HIV-1 Tat transactivator protein: a therapeutic target? Fulcher AJ; Jans DA IUBMB Life; 2003 Dec; 55(12):669-80. PubMed ID: 14769003 [TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-1 induces cleavage of exogenous alphaB-crystallin transduced by a cell-penetrating peptide. Yang SW; Lee SM; Choi EY; Lee KH; Kim SH; Shin MJ; Han YS; Kang SM; Chung JH J Cell Biochem; 2011 Sep; 112(9):2454-62. PubMed ID: 21538481 [TBL] [Abstract][Full Text] [Related]
14. HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors. Johnston JB; Zhang K; Silva C; Shalinsky DR; Conant K; Ni W; Corbett D; Yong VW; Power C Ann Neurol; 2001 Feb; 49(2):230-41. PubMed ID: 11220743 [TBL] [Abstract][Full Text] [Related]
15. Synthetic HIV-1 Tat can dissociate HeLa nuclear protein-TAR RNA complexes in vitro: a novel Tat-nuclear protein interaction. Jeyapaul J; Seshamma T; Khan SA Oncogene; 1991 Sep; 6(9):1507-13. PubMed ID: 1923518 [TBL] [Abstract][Full Text] [Related]
16. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif. Kundu M; Ansari SA; Chepenik LG; Pomerantz RJ; Khalili K; Rappaport J; Amini S J Hum Virol; 1999; 2(2):72-80. PubMed ID: 10225209 [TBL] [Abstract][Full Text] [Related]
17. Block of Tat-mediated transactivation of tumor necrosis factor beta gene expression by polymeric-TAR decoys. Brother MB; Chang HK; Lisziewicz J; Su D; Murty LC; Ensoli B Virology; 1996 Aug; 222(1):252-6. PubMed ID: 8806505 [TBL] [Abstract][Full Text] [Related]
18. HIV secreted protein Tat prevents long-term potentiation in the hippocampal CA1 region. Behnisch T; Francesconi W; Sanna PP Brain Res; 2004 Jun; 1012(1-2):187-9. PubMed ID: 15158177 [TBL] [Abstract][Full Text] [Related]
19. HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Kruman II; Nath A; Mattson MP Exp Neurol; 1998 Dec; 154(2):276-88. PubMed ID: 9878167 [TBL] [Abstract][Full Text] [Related]
20. Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport. Chauhan A; Turchan J; Pocernich C; Bruce-Keller A; Roth S; Butterfield DA; Major EO; Nath A J Biol Chem; 2003 Apr; 278(15):13512-9. PubMed ID: 12551932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]